{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "CENP-E_Inhibitor_GSK-923295A",
  "nciThesaurus": {
    "casRegistry": "1088965-37-0",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A small-molecule inhibitor of the mitotic kinesin centromere-associated protein E (CENP-E), with potential antineoplastic activity. Upon administration, GSK-923295A binds to and inhibits CENP-E, thereby preventing cell division, inducing cell cycle arrest, and ultimately leading to an inhibition of cell proliferation. CENP-E, a kinetochore-associated mitotic kinesin, plays an essential role in chromosome movement during mitosis and regulates cell-cycle transition from metaphase to anaphase.",
    "fdaUniiCode": "072702W9QD",
    "identifier": "C91080",
    "preferredName": "CENP-E Inhibitor GSK-923295A",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C273"
    ],
    "synonyms": [
      "CENP-E Inhibitor GSK-923295A",
      "Centromere-Associated Protein E Inhibitor GSK-923295",
      "GSK 923295",
      "GSK 923295A",
      "GSK-923295",
      "GSK-923295A",
      "GSK923295",
      "GSK923295A"
    ]
  }
}